"10.1371_journal.pone.0075608","plos one","2013-09-24T00:00:00Z","Sara Lodi; Andrew Phillips; Sarah Fidler; David Hawkins; Richard Gilson; Ken McLean; Martin Fisher; Frank Post; Anne M Johnson; Louise Walker-Nthenda; David Dunn; Kholoud Porter; on behalf of the UK Register of HIV","Medical Research Council, University College London, London, United Kingdom; Instituto de Salud Carlos III, Madrid, Spain; University College London, London, United Kingdom; Imperial College NHS Trust, London, United Kingdom; Chelsea and Westminster Hospital, London, United Kingdom; Mortimer Market Centre and University College London Hospitals, London, United Kingdom; Charing Cross Hospital, London, United Kingdom; Brighton and Sussex University Hospital National Health Service Trust, Brighton, United Kingdom; Kingâ€™s College, London, United Kingdom","Analyzed the data: SL. Wrote the manuscript: SL KP. Concept and design: SL KP AP. Statistical analyses: SL. Interpretation of the data: SL KP. Drafting of the manuscript: SL KP. Critical revision of the manuscript: SL AP SF DH RG KM MF FP AMJ LWN DD KP. Acquisition of data: SF DH RG KM MF LWN DD FP. Securing funding: KP DD. Had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis: SL.","KP has received an honorarium from Tibotec. AP has received reimbursement for either/or: attending a symposium; a fee for speaking; a fee for organising education; funds for research; funds for a member of staff; fees for consulting from various pharmaceutical companies including: Roche, BMS, GSK, Abbott, Boehringer-Ingelheim, Gilead, Tibotec, Oxxon Therapeutics. There are no patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2013","09","Sara Lodi","SL",13,TRUE,NA,NA,1,2,TRUE,TRUE,TRUE,1,"13",TRUE
